S
Santosh
About Santosh
Data last updated:
Santosh is a Director at Attollent Pharmaceuticals Private Limited (since 2022). The company operates in Trading. Attollent Pharmaceuticals Private Limited reported revenue of ₹3.18 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Apr 2022 | 2011 | ₹3.18 Cr (FY 2025) | Active |
Board colleagues of Santosh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rishi Bhagawat Dayal | 10376840 | Attollent Pharmaceuticals Private Limited | Director |
| Sachin Kumar Bahot | 10994668 | Attollent Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Santosh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Santosh
Santosh currently holds 1 directorship: Attollent Pharmaceuticals Private Limited (Director, since 30 Apr 2022, revenue ₹3.18 Cr (FY 2025)).
Santosh was first appointed on 30 Apr 2022 as Director at Attollent Pharmaceuticals Private Limited.
The current boards of Santosh's companies include Rishi Bhagawat Dayal (Attollent Pharmaceuticals Private Limited), Sachin Kumar Bahot (Attollent Pharmaceuticals Private Limited).